In NAFLD, fatty acids accumulate in hepatocytes and reduce hepatic insulin sensitivity, thereby promoting hepatic gluconeogenesis, thereby increasing the risk of type 2 diabetes (T2D) or exacerbating disease pathology in diabetic patients (25, 26). The gene discussed is INS; the disease is type 2 diabetes mellitus.